Assignee
Orionis Biosciences BV
BE·12 granted patents·6 pending applications·49 citations·filing 2016–2025
Top patents by PatentIndex Score
18 records- 0194US11236166B2CD8 binding agentsOrionis Biosciences BV·Filed 2017·Granted Feb 1, 2022·10 cites·9 claims
- 0294US11001631B2Clec9A binding agentsOrionis Biosciences BV·Filed 2017·Granted May 11, 2021·12 cites·17 claims
- 0392US11236141B2Targeted mutant interferon-beta and uses thereofOrionis Biosciences BV·Filed 2017·Granted Feb 1, 2022·7 cites·16 claims
- 0491US10988538B2Bispecific signaling agents and uses thereofOrionis Biosciences BV·Filed 2017·Granted Apr 27, 2021·9 cites·45 claims
- 0588US11661455B2Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moietyOrionis Biosciences BV·Filed 2017·Granted May 30, 2023·4 cites·6 claims
- 0687US2026069686A1Cd8 binding agentsOrionis Biosciences BV·Filed 2025·Application pending·0 cites
- 0786US11384154B2Targeted chimeric proteins and uses thereofOrionis Biosciences BV·Filed 2018·Granted Jul 12, 2022·5 cites·12 claims
- 0879US12364753B2CD8 binding agentsOrionis Biosciences BV·Filed 2021·Granted Jul 22, 2025·0 cites·16 claims
- 0979US11753463B2Therapeutic targeting of non-cellular structuresOrionis Biosciences BV·Filed 2017·Granted Sep 12, 2023·2 cites·13 claims
- 1076US12453770B2CLEC9A binding agentsOrionis Biosciences BV·Filed 2021·Granted Oct 28, 2025·0 cites·11 claims
- 1173US12497436B2Chimeric protein, and encoding nucleic acid thereof, comprising interferon-β and a targeting moiety comprising a single-domain antibody or single-chain antibodyOrionis Biosciences BV·Filed 2021·Granted Dec 16, 2025·0 cites·9 claims
- 1272US2023399406A1Targeted therapeutic agents and uses thereofOrionis Biosciences BV·Filed 2023·Application pending·0 cites
- 1370US2021139586A1Bispecific signaling agents and uses thereofOrionis Biosciences BV·Filed 2020·Application pending·0 cites
- 1469US12522641B2Targeted mutant interferon-gamma and uses thereofOrionis Biosciences BV·Filed 2021·Granted Jan 13, 2026·0 cites·17 claims
- 1569US2024025980A1Therapeutic targeting of non-cellular structuresOrionis Biosciences BV·Filed 2023·Application pending·0 cites
- 1668US2022281992A1Targeted chimeric proteins and uses thereofOrionis Biosciences BV·Filed 2022·Application pending·0 cites
- 1765US2023287131A1Bi-functional chimeric proteins and uses thereofOrionis Biosciences BV·Filed 2023·Application pending·0 cites
- 1849US11702477B2Bi-functional chimeric proteins and uses thereofOrionis Biosciences BV·Filed 2016·Granted Jul 18, 2023·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Orionis Biosciences BV files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →